We produce advanced, validated, commercial-ready 3D lung models. Designed to assess toxicity in the drug discovery process and already tested for infection with the SARS-COV-2 virus.

This model has already undergone a complete validation process, ensuring its accuracy and reliability. This innovative technology represents a significant advancement in the healthcare field, offering a detailed three-dimensional representation.
 

Our model already has a patent licensing request in progress, showcasing the recognition of the uniqueness and potential impact of this technology in the industry, contributing to the development of advanced solutions.